Ganga Pharmaceuticals Ltd - 539680 - Compliance Certificate Issued Pursuant To Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2024
Please find attached herewith the Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the Financial Year ended on March 31, 2024 Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74(5) of the SEBI (DP) Regulation, 2018 for the quarter ended on March 31, 2024 Ganga Pharmaceuticals Ltd - 539680 - Closure of Trading Window
Intimation for Trading Window Closure Ganga Pharmaceuticals Ltd - 539680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Prakash Dhirajlal Tanna Ganga Pharmaceuticals Ltd - 539680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bhavesh Dhirajilal Tanna Ganga Pharmaceuticals Ltd - 539680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd Ganga Pharmaceuticals Ltd - 539680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Plutus Capital Management LLP Ganga Pharmaceuticals Ltd - 539680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Bharat Brijmohan Sharma Ganga Pharmaceuticals Ltd - 539680 - Announcement under Regulation 30 (LODR)-Allotment
Intimation under Regulation 30 of SEBI(Listing Obligation and Disclosure Requirements) Regulation, 2015-Allotment of 7,75,000 Equity Shares and Allotment of 17,75,000 Warrants on Preferential Basis. Ganga Pharmaceuticals Ltd - 539680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2023